Genetic Technologies Limited Announces Executive Changes
September 9, 2019. As announced on 11 July 2019 Dr. Kasian was acting Chief Executive Officer during the company's recruitment process. The Company intends to continue that recruitment process to appoint a new Chief Executive Officer and, in the interim, Dr. George Muchnicki will now assume the role as acting Chief Executive. The Board has already initiated the search for a new director and Chair and hopes to soon make an announcement informing the market regarding this.